In the case of prostate cancer, overexpressed EpCAM associated with progression and distant metastasis [45], whereas increased 10-year survival rate of gastric cancer patients was confirmed to correlate with the increased EpCAM [46]. This evidence concerns the gene EPCAM and prostate cancer.